Please login to the form below

Not currently logged in
Email:
Password:

ALK Abelló's John Tarplee joins Adherium

Becomes business development SVP for Europe

Adherium John TarpleeMelbourne-based Adherium Limited has appointed John Tarplee to the newly-created position of senior vice president of business development, Europe.

Tarplee will responsible for leading market development and partnering for the digital health technology firm's European business, which was established in conjunction with his appointment and is based in Guildford, UK.

He brings over 30 years of sales and market expansion expertise, most recently in the role of senior vice president at Danish immunotherapy company ALK Abelló where he oversaw its commercial operations and geographical expansion strategy.

Prior to this, Tarplee has held several management level roles at Sanofi, including business unit director UK, and he has also worked for Abbott Laboratories and Fisons Pharmaceuticals.

Garth Sutherland, chief executive officer of Adherium, said: “I am delighted to welcome John to the team and to be establishing a formal base of operations on the ground in Europe.

“Attracting a senior business development executive of this calibre to expand our footprint and market presence is a strong endorsement of our technology and business model.”

8th April 2016

From: Sales

Share

Tags

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Virgo Health

Virgo Health is an award-winning global healthcare communications and medical education agency. We dispense pioneering and creative campaigns, driven by...

Latest intelligence

Enabling market access through outcomes-based pricing
Outcomes-based pricing is a potential solution to create a link between product price and real-world outcomes, while at the same time facilitating patient access to new and innovative medicines....
Five companies 20 for 2020
20 for 2020 – Five pharma companies to watch
As a new decade gets into gear, we take a look at five pharma companies that have a lot riding on 2020...
The growing clinical importance of patient-reported outcomes (PROs)
Traditionally, the success or otherwise of medical treatments has been assessed by mortality or clinical assessments of health. However, patient self-reports of health are increasingly seen as central to the...

Infographics